Terry Arnold, PA-C, shares a wide range of opportunities to take clinical experience to a different setting and tips to transition.
Loretta Fiorillo, MD, FRCPC, reviews key data points from the phase 3 SPROUT study.
Aubrie Jones, PA-C, MMS, and Laura Bush, DMSc, PA-C, DFAAPA, discuss the role of the SDPA in supporting the growth and journeys of PAs at all stages.
What's new in the treatment of mucoid pseudocysts? An international researcher and clinicians shares insights.
Jeremy Youse, M.D., founding partner, medical director and practicing dermatologist at VitalSkin Dermatology discusses which tasks he and other dermatologists want control over to get the most out of practicing and running their offices efficiently each day.
Robert Sidbury, MD, MPH, addresses the similarities and differences between the AAD’s recent atopic dermatitis guidelines and other guidelines from various groups and countries.
A survey asked dermatologists whether they had personal treated head and neck melanoma with excision, and if and when they referred patients with melanoma on the head and neck to a Mohs surgeon.
With the release of three brand-new products, ALASTIN Skincare® is introducing a new line of sensitive skin products that include our proprietary TriHex Technology® along with other active ingredients.
Check out these 5 factors that can significantly impact a dermatologist’s financial plan and should therefore incorporate flexibility and resiliency to structure the plan for long-term success.
A prebiotic cleanser and moisturizer regimen not only significantly alleviated the severity of atopic dermatitis and xerosis, but also uncovered crucial differences in symptom experiences.
There are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.
Investigators suggest parents and clinicians should be mindful of children with suspected ACD with a history of exposure to jewelry, clothing, and belts with cobalt.
Lenvatinib and pembrolizumab continued to yield meaningful and durable responses in patients with advanced melanoma who had progressed on previous PD-L1 inhibitor treatment.
In this episode, Albert Yan, MD, FAAP, FAAD, discusses his SPD 2024 session revolving around the helpful (or hindering?) role of artificial intelligence and chatbots in dermatology.
Physicians across the US saw an uptick in cosmetic procedures after workers returned to offices.
Ruchi Gupta, MD, MPH, shares tips for supporting a successful transition to college for patients with atopic dermatitis.
The September 2023 issue of Dermatology Times featured a spotlight on psoriasis research, advances, and treatment options in patients with skin of color. Learn more about the topics covered in each spotlight article.